These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16397549)

  • 21. Metabolic complications of obesity: inflated or inflamed?
    Chandalia M; Abate N
    J Diabetes Complications; 2007; 21(2):128-36. PubMed ID: 17331862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance syndrome and polycystic ovary syndrome: implications for diagnosis and treatment.
    Tan S; Hahn S; Janssen OE
    Panminerva Med; 2005 Dec; 47(4):211-7. PubMed ID: 16489320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome: is it a syndrome? Does it matter?
    Kahn R
    Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolic syndrome and the menopause.
    Kaaja RJ
    Menopause Int; 2008 Mar; 14(1):21-5. PubMed ID: 18380957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Danger ahead. Identifying insulin resistance.
    Wade M
    Adv Nurse Pract; 2008 Aug; 16(8):61-5. PubMed ID: 19181180
    [No Abstract]   [Full Text] [Related]  

  • 26. Abdominal obesity and metabolic syndrome.
    Després JP; Lemieux I
    Nature; 2006 Dec; 444(7121):881-7. PubMed ID: 17167477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controversy in diagnosis and management of the metabolic syndrome.
    Brietzke SA
    Med Clin North Am; 2007 Nov; 91(6):1041-61, vii-viii. PubMed ID: 17964908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolic syndrome--from insulin resistance to obesity and diabetes.
    Gallagher EJ; LeRoith D; Karnieli E
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):559-79, vii. PubMed ID: 18775352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers.
    Lee S; Bacha F; Gungor N; Arslanian S
    J Pediatr; 2008 Feb; 152(2):177-84. PubMed ID: 18206686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome.
    Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
    Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
    J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Obesity, inflammation and diabetes].
    Miranda-Garduño LM; Reza-Albarrán A
    Gac Med Mex; 2008; 144(1):39-46. PubMed ID: 18619057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The diabolic syndrome].
    Järhult B
    Lakartidningen; 2004 Sep; 101(36):2746-7. PubMed ID: 15455640
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of metabolic profile in a clinical setting.
    Pervanidou P; Kanaka-Gantenbein C; Chrousos GP
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):589-95. PubMed ID: 16912555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes mellitus: complications and therapeutics.
    Tripathi BK; Srivastava AK
    Med Sci Monit; 2006 Jul; 12(7):RA130-47. PubMed ID: 16810145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic complications of obesity in childhood and adolescence: more than just diabetes.
    Nathan BM; Moran A
    Curr Opin Endocrinol Diabetes Obes; 2008 Feb; 15(1):21-9. PubMed ID: 18185059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The metabolic syndrome--clinical significance in 2011. Position statement of the Hungarian Diabetes Society, Metabolism Work Group].
    Barkai L; Halmos T; Hidvégi T; Jermendy G; Korányi L; Madácsy L; Pados G; Winkler G;
    Orv Hetil; 2011 Sep; 152(36):1450-8. PubMed ID: 21865147
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
    Ahmed I; Goldstein BJ
    Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In addition to insulin resistance and obesity, hyperuricemia is strongly associated with metabolic syndrome using different definitions in Chinese populations: a population-based study (Taichung Community Health Study).
    Lin WY; Liu CS; Li TC; Lin T; Chen W; Chen CC; Li CI; Lin CC
    Ann Rheum Dis; 2008 Mar; 67(3):432-3. PubMed ID: 18292110
    [No Abstract]   [Full Text] [Related]  

  • 40. The metabolic syndrome, diabetes and lung dysfunction.
    Tiengo A; Fadini GP; Avogaro A
    Diabetes Metab; 2008 Nov; 34(5):447-54. PubMed ID: 18829364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.